West Oak Capital LLC Cuts Holdings in Colgate-Palmolive (NYSE:CL)

West Oak Capital LLC reduced its position in shares of Colgate-Palmolive (NYSE:CL) by 0.5% in the 3rd quarter, Holdings Channel.com reports. The firm owned 27,457 shares of the company’s stock after selling 135 shares during the period. Colgate-Palmolive comprises about 0.5% of West Oak Capital LLC’s holdings, making the stock its 26th largest position. West Oak Capital LLC’s holdings in Colgate-Palmolive were worth $2,850,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the stock. Aaron Wealth Advisors LLC boosted its position in shares of Colgate-Palmolive by 18.6% in the 3rd quarter. Aaron Wealth Advisors LLC now owns 11,454 shares of the company’s stock valued at $1,189,000 after purchasing an additional 1,796 shares during the period. V Square Quantitative Management LLC boosted its holdings in shares of Colgate-Palmolive by 5.2% in the third quarter. V Square Quantitative Management LLC now owns 15,332 shares of the company’s stock valued at $1,592,000 after acquiring an additional 756 shares during the period. Sax Wealth Advisors LLC lifted its stake in shares of Colgate-Palmolive by 73.5% in the 3rd quarter. Sax Wealth Advisors LLC now owns 4,279 shares of the company’s stock worth $444,000 after acquiring an additional 1,813 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd boosted its holdings in shares of Colgate-Palmolive by 3.7% in the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 96,996 shares of the company’s stock valued at $10,069,000 after acquiring an additional 3,432 shares in the last quarter. Finally, NatWest Group plc increased its stake in shares of Colgate-Palmolive by 138.3% during the third quarter. NatWest Group plc now owns 109,424 shares of the company’s stock worth $11,359,000 after acquiring an additional 63,511 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.4 %

Shares of Colgate-Palmolive stock opened at $100.46 on Friday. The business has a 50 day moving average price of $103.43 and a 200 day moving average price of $97.54. The company has a market capitalization of $82.42 billion, a P/E ratio of 31.79, a P/E/G ratio of 3.54 and a beta of 0.40. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.70. Colgate-Palmolive has a 1 year low of $71.46 and a 1 year high of $109.30.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, July 26th. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.87 by $0.04. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. The company had revenue of $5.06 billion during the quarter, compared to analysts’ expectations of $5 billion. During the same period in the previous year, the firm posted $0.77 earnings per share. The business’s revenue for the quarter was up 4.9% compared to the same quarter last year. Sell-side analysts anticipate that Colgate-Palmolive will post 3.57 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a $0.50 dividend. The ex-dividend date is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 1.99%. Colgate-Palmolive’s dividend payout ratio (DPR) is 63.29%.

Analyst Upgrades and Downgrades

CL has been the subject of a number of recent analyst reports. Wells Fargo & Company downgraded shares of Colgate-Palmolive from an “equal weight” rating to an “underweight” rating and set a $100.00 price objective for the company. in a research report on Monday, September 16th. Bank of America lifted their price target on Colgate-Palmolive from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, July 10th. HSBC reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Deutsche Bank Aktiengesellschaft downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and raised their target price for the company from $107.00 to $109.00 in a report on Monday, September 9th. Finally, UBS Group upped their price target on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $106.00.

Insiders Place Their Bets

In related news, insider Sally Massey sold 15,850 shares of the company’s stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the transaction, the insider now owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, EVP Gregory Malcolm sold 10,533 shares of the company’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.10, for a total transaction of $1,085,952.30. Following the completion of the transaction, the executive vice president now owns 10,377 shares of the company’s stock, valued at $1,069,868.70. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the sale, the insider now directly owns 13,942 shares in the company, valued at $1,439,929.76. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 43,490 shares of company stock valued at $4,486,063 in the last ninety days. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.